FDA To Pilot Biosimilar Regulatory Science Program

Scheme Will Focus On Advancing Interchangeable Development And Improving Efficiency

 
• By Chloe Kent

As part of BsUFA III, the FDA has announced that it will be commencing its regulatory science research program, which will focus on advancing the development of interchangeable products and biosimilars.

Official homepage of the FDA
The FDA is examining interchangeability as part of the program • Source: Shutterstock

More from Biosimilars

More from Products